Navigation Links
Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Date:5/30/2012

SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.

Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot™ (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS®  drug discovery information management workspace, the Accelrys Discovery Studio® modeling and simulation application and Accelrys Biological Registration software.

"Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Center. "With upw
'/>"/>

SOURCE Accelrys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Acknowledges Accelrys for Scientific Informatics Solution
2. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
3. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
4. Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
5. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
6. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
7. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
8. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
9. Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone)
10. Watson Announces Lidoderm® Patent Challenge Settlement
11. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research ... announced the addition of the "The Corporate ... 2014 - Global Edition " report to ... Pharmafrom a Patient Perspective, is now in its ... (2014 results; published early 2015). For each annual ...
(Date:4/17/2015)... , April 17, 2015 Bionomics Limited (ASX:BNO, ... development of innovative therapeutics for the treatment of cancer ... the presentation of data from three of its most ... Cancer Research (AACR) 106 th Annual Meeting being ... PA USA. The presentation ...
(Date:4/16/2015)... 2015 Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today that it ... Annual Report on Form 20-F that included audited ... An electronic version of Mindray,s Annual Report on ... website at  http://ir.mindray.com  or  http://www.sec.gov . ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... (NASDAQ: SPEX ) -- an innovator in ... and providers of technical and regulatory consulting services to ... that Dr. Claire Kruger, Chief Executive Officer, and Dr. ... at the Rodman & Renshaw 13th Annual Healthcare Conference ...
... a article published in the August issue of the Journal ... Distinguished Professor of Health Law & Executive Director, Institute of ... and Mr. Tim Mackey, Senior Research Associate at IHLS and ... California, San Diego – San Diego State University, assess the ...
Cached Medicine Technology:Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2JMIR Article by IHLS Authors Discusses Global Public Health Implications of Social Media Direct-to-Consumer Advertising by Illicit Online Pharmacies and Private Entities 2
(Date:4/19/2015)... April 19, 2015 McCann Investigations, a ... announce the publication of white paper Married, but ... As online media provides a unique environment of ... market specifically targeting adulterous spouses has emerged. Social ... becomes as easy as shopping online. Dating sites ...
(Date:4/19/2015)... 19, 2015 HealthPostures, LLC , a ... it will exhibit it’s pioneering ergonomics products at the ... Iowa-Illinois Safety Council Professional Development Conference and Expo . ... EZ are used in volume by call centers, educational ... Built to clamp to a desk, the TaskMate Go ...
(Date:4/18/2015)... April 18, 2015 Compare-autoinsurance.org has released ... reliable auto insurance policy . , Clients ... car insurance quotes online is safe and reliable. An ... The quotes are displayed on a single web page, ... , It is now possible to compare online ...
(Date:4/18/2015)... Carinsurancehints.com has released a new blog post explaining how ... protection against fire damage. , Clients can now find ... vehicle is set intentionally on fire. This type of damages ... other things. , It is possible to compare the ... http://www.carinsurancehints.com/ , in just a few minutes. Clients should ...
(Date:4/18/2015)... Review of Ophthalmology magazine and Abbot ... Success’ program for cataract surgeons attending the American Society ... where eye surgeon Jeffrey L. Martin, MD will serve ... Martin is the Managing Partner of North Shore Eye ... Martin to lead this year’s discussion on the latest ...
Breaking Medicine News(10 mins):Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... N.Y. -- Today,s major announcement at the American Society ... significantly reduces the risk of breast cancer in high-risk, ... double-blind phase III clinical trial in which University at ... played a critical role. The findings will be ...
... Steven Reinberg HealthDay Reporter , FRIDAY, June ... can see their chances of the cancer,s return drop ... added to regular hormone therapy for three years after ... for breast cancer are prone to develop osteoporosis, so ...
... Ellin Holohan HealthDay Reporter , FRIDAY, June ... help ease the hot flashes, night sweats and insomnia ... of Massachusetts research showed that mindfulness training, based on ... hot flashes and improved physical, psychosocial and sexual functioning. ...
... -- ASCO Abstract #10504. Contrary to what many oncologists had ... reduce the effectiveness of the breast cancer drug Herceptin, according ... North Central Cancer Research Group (NCCTG) investigators. The study, ... NCCTG N9831 clinical trial, found that patients with HER2-positive breast ...
... each targeting a prime survival strategy of tumors, can ... either drug alone for advanced, inoperable melanomas, according to ... Institute investigators. The findings (abstract 8511), will be ... of the American Society of Clinical Oncology on Saturday, ...
... Customizing targeted therapies to each tumor,s molecular characteristics, ... be more effective for some types of cancer, according ... Anderson Cancer Center. MD Anderson,s Phase I findings ... the 47th Annual Meeting of the American Society of ...
Cached Medicine News:Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 2Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 3Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 2Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 3Health News:Meditation May Help Women Cope With Hot Flashes 2Health News:Meditation May Help Women Cope With Hot Flashes 3Health News:Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drug 2Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 2Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 3Health News:Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: